Iprazest Respules
Information About Iprazest Respules
About Iprazest Respules
Medicine Brand Iprazest Respules is manufactured by Macleods Pharmaceuticals Pvt Ltd and mainly contents the generic drug Ipratropium Bromide.
Pakaging
4
Active Ingredients For Iprazest Respules
Ipratropium Bromide 500 mcg Levosalbutamol 125 mg
Diseases List For Which Iprazest Respules Is Prescribed
This Drug Is Prescribed For Reversible airways obstruction Rhinorrhoea associated with rhinitis
Other Significations For Iprazest Respules
This Medication Ipratropium bromide is a bronchodilator that dilates enlarges airways bronchi in the lungs It is used in treating symptoms of asthma colds allergies and chronic obstructive pulmonary disease COPD due to emphysema or chronic bronchitis Ipratropium blocks the effect of acetylcholine on airways bronchi and nasal passages Acetylcholine is a chemical that nerves use to communicate with muscle cells In asthma and chronic obstructive pulmonary disease cholinergic nerves going to the lungs cause narrowing of the airways by stimulating muscles surrounding the airways to contract The anticholinergic effect of ipratropium blocks the effect of cholinergic nerves causing the muscles to relax and airways to dilate Mucus glands in the nose also are controlled by nerves that use acetylcholine to communicate By blocking acetylcholine ipratropium helps relieve symptoms of allergies and the common cold by preventing secretion of mucus by mucus glands in the nose When inhaled ipratropium travels directly to airways and very little is absorbed into the body The FDA approved ipratropium in October 1995
Precautions To Be Taken Before Iprazest Respules
Use with other anticholinergic drugs for example atropine may increase the occurrence of side effects
Major Conditions And Care
Pregnancy And Iprazest Respules
Can We Take Iprazest Respules During Pregnancy?
Pregnancy Class : C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and wellcontrolled studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks
Lactation And Iprazest Respules
Can We Use Iprazest Respules During Lactation
Lactation Class L4 There is positive evidence of risk to a breastfed infant or to breastmilk production but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant eg if the drug is needed in a lifethreatening situation or for a serious disease for which safer drugs cannot be used or are ineffective
Side Effects Of Iprazest Respules
Nausea stomach upset skin rash acute toxicity